View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 19, 2011

Valeant to Acquire Ortho Dermatologics

Valeant Pharmaceuticals North America and Valeant International (Barbados) have signed an agreement to acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals for $345m. The acquisition assets includes prescription brands Retin-A Micro, Ertaczo and Renova.

By cms admin

Valeant Pharmaceuticals North America and Valeant International (Barbados) have signed an agreement to acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals for $345m.

The acquisition assets includes prescription brands Retin-A Micro, Ertaczo and Renova.

The transaction is subject to certain closing conditions and regulatory approvals and is expected to be completed later this year.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology